7435745

2 known cases. View patent page →

Cases
2
Active
0
2 closed
Filed
2007–2015
Top venue
D. New Jersey
2 cases

Celgene Corporation v. Lannett Holdings, Inc.

settled
Docket:
2:15-cv-00697
Filed:
2015-01-30
Patents:79595667435745
π Celgene CorporationΔ Lannett Holdings, Inc.

Celgene filed an ANDA patent infringement action against Lannett over generic thalidomide (Lannett ANDA No. 206601), asserting fifteen patents. The parties settled in 2017, with Lannett converting its Paragraph IV certification on the '745 patent to a Paragraph III certification and receiving a license to market generic thalidomide as of August 1, 2019. The narrative could not confirm that U.S. 7,959,566 was among the fifteen asserted patents.

Celgene Corporation v. Barr Laboratories, Inc. et al.

dismissed
Docket:
2:07-cv-00286
Filed:
2007-01-18
Terminated:
2010-05-21
Patents:7435745
π Celgene CorporationΔ Barr Laboratories, Inc.Δ Barr Pharmaceuticals, Inc.

Hatch-Waxman litigation concerning Barr's thalidomide ANDA for generic Thalomid. The '745 patent issued after the complaint was filed and is associated with this case on Google Patents, but the narrative could not confirm it was directly asserted; the case was dismissed on May 21, 2010, after Barr withdrew its ANDA, with Barr's counterclaims dismissed with prejudice.